30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Orthofix M6-C Disc in First U.S. Patients Following PMA -

Orthofix Medical announced first commercial U.S. implants of the M6-C™ cervical disc following FDA Premarket Approval of the device, which occurred in 1Q19. M6-C is designed to restore physiologic motion to the spine at the treated level, and features an artificial viscoelastic nucleus and fiber annulus that mimics the anatomic structure of a natural disc. It presents an alternative to cervical fusion for eligible patients. The device is in controlled, limited U.S. market launch. Outside of the U.S., M6-C has been implanted more than 45,000 times. (Source: Orthofix Medical Inc., 4/23/19)